50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
S&P 500   3,719.04 (+1.97%)
DOW   29,683.74 (+1.88%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
NASDAQ:PRE

Prenetics Global - PRE Stock Forecast, Price & News

$3.76
+0.16 (+4.44%)
(As of 09/28/2022 05:19 PM ET)
Add
Compare
Today's Range
$3.59
$3.78
50-Day Range
$3.45
$4.26
52-Week Range
$3.33
$8.75
Volume
13,553 shs
Average Volume
81,880 shs
Market Capitalization
$165.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PRE stock logo

About Prenetics Global (NASDAQ:PRE) Stock

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Receive PRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter.

PRE Stock News Headlines

Prenetics Global (NASDAQ:PRE) Stock Price Up 0.3%
Hong Kong SPAC Market Wilts as Global Fever Ebbs
Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M
Prenetics Global Limited (PRE)
Prenetics Global Limited Warrant (PRENW)
Prenetics Global Ltd (PRE)
See More Headlines
Receive PRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter.

PRE Company Calendar

Today
9/28/2022
Next Earnings (Estimated)
11/21/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRE
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.62) per share

Miscellaneous

Free Float
N/A
Market Cap
$165.13 million
Optionable
Not Optionable
Beta
0.31

Key Executives

  • Mr. Sheng Wu Yeung (Age 43)
    Co-Founder, Chairperson & CEO
  • Dr. Chi Hung Tzang Ph.D. (Age 48)
    Co-Founder & Chief Scientific Officer
  • Mr. Hoi Chun Lo (Age 37)
    Chief Financial Officer
  • Dr. Yung Ho Wong DPHIL (Age 40)
    Chief Technology Officer
  • Ms. Yvonne L. Wong
    Chief Corp. Devel. Officer
  • Mr. Chun Yu Chan (Age 42)
    Chief People Officer
  • Dr. Senthil Sundaram M.D. (Age 48)
    Chief Clinical Officer
  • Mr. Avrom Boris Lasarow (Age 46)
    Chief Exec. Officer of EMEA
  • Dr. Shih-Chang Ong M.D. (Age 45)
    Chief Medical Officer
  • Dr. Wu Po Ma Ph.D. (Age 57)
    Head of R&D













PRE Stock - Frequently Asked Questions

Should I buy or sell Prenetics Global stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prenetics Global in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRE shares.
View PRE analyst ratings
or view top-rated stocks.

How have PRE shares performed in 2022?

Prenetics Global's stock was trading at $5.73 at the beginning of the year. Since then, PRE shares have decreased by 37.2% and is now trading at $3.60.
View the best growth stocks for 2022 here
.

When is Prenetics Global's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our PRE earnings forecast
.

What guidance has Prenetics Global issued on next quarter's earnings?

Prenetics Global updated its third quarter 2022 earnings guidance on Friday, September, 23rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $65.00 million-$70.00 million, compared to the consensus revenue estimate of $76.93 million.

What is Prenetics Global's stock symbol?

Prenetics Global trades on the NASDAQ under the ticker symbol "PRE."

Who are Prenetics Global's major shareholders?

Prenetics Global's stock is owned by a number of retail and institutional investors. Top institutional investors include Millennium Management LLC (0.80%) and NINE MASTS CAPITAL Ltd (0.11%).

How do I buy shares of Prenetics Global?

Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prenetics Global's stock price today?

One share of PRE stock can currently be purchased for approximately $3.60.

How much money does Prenetics Global make?

Prenetics Global (NASDAQ:PRE) has a market capitalization of $158.10 million.

How can I contact Prenetics Global?

Prenetics Global's mailing address is 71 Fort Street PO Box 500, Grand Cayman E9, KY1-1106. The official website for the company is www.prenetics.com. The company can be reached via phone at 852 2210 9588.

This page (NASDAQ:PRE) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.